Home Biosimilar Antibodies Immunology & Inflammation CD markers antibody Tidutamab (Anti-CD3 & SSTR2) For research use only.
Not for use in humans.

Tidutamab (Anti-CD3 & SSTR2)

Synonyms: XmAb-18087

Tidutamab (Anti-CD3 & SSTR2) is a humanized and affinity-optimized bispecific antibody (bsAb) targeting SSTR2 binding domain and T-cell binding domain (CD3). It can be used in neuroendocrine tumors (NETs) and small cell lung cancer (SCLC). MW :147.36 KD.

Tidutamab (Anti-CD3 & SSTR2)

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description Tidutamab (Anti-CD3 & SSTR2) is a humanized and affinity-optimized bispecific antibody (bsAb) targeting SSTR2 binding domain and T-cell binding domain (CD3). It can be used in neuroendocrine tumors (NETs) and small cell lung cancer (SCLC). MW :147.36 KD.

Product Details

CAS No. 2148354-90-7
Isotype Human IgG1
Source CHO
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Tidutamab (Anti-CD3 & SSTR2) | Tidutamab (Anti-CD3 & SSTR2) supplier | purchase Tidutamab (Anti-CD3 & SSTR2) | Tidutamab (Anti-CD3 & SSTR2) cost | Tidutamab (Anti-CD3 & SSTR2) manufacturer | order Tidutamab (Anti-CD3 & SSTR2) | Tidutamab (Anti-CD3 & SSTR2) distributor